{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:07:14Z","timestamp":1760044034311},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11239-019-01813-0","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T08:34:06Z","timestamp":1548318846000},"page":"192-199","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["\u201cBlueprinting\u201d thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke"],"prefix":"10.1007","volume":"47","author":[{"given":"Kevin P.","family":"Bliden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabe","family":"Raviv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliano P.","family":"Navarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tricia","family":"Brannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"1813_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics, Stroke Statistics Subcommitee (2017) Heart disease and stroke statistics-2017 update: a report from the american heart association. Circulation 135:e146\u2013e603. \n                    https:\/\/doi.org\/10.1161\/CIR.0000000000000485","journal-title":"Circulation"},{"key":"1813_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, American Heart Association Stroke, Council on Cardiovascular and Stroke Nursing, Council on Peripheral Vascular, Council on Clinical Cardiology (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 44:870\u2013947. \n                    https:\/\/doi.org\/10.1161\/STR.0b013e318284056a","journal-title":"Stroke"},{"key":"1813_CR3","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL, American Heart Association Stroke C (2018) 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 49:e46\u2013e110. \n                    https:\/\/doi.org\/10.1161\/STR.0000000000000158","journal-title":"Stroke"},{"key":"1813_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejvs.2017.03.024","volume":"54","author":"K Spanos","year":"2017","unstructured":"Spanos K, Kouvelos G, Matsagkas M, Giannoukas AD (2017) Antiplatelet resistance in ischaemic stroke patients. Eur J Vasc Endovasc Surg 54:3\u20134. \n                    https:\/\/doi.org\/10.1016\/j.ejvs.2017.03.024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1813_CR5","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1212\/WNL.0000000000002657","volume":"86","author":"MS Oh","year":"2016","unstructured":"Oh MS, Yu KH, Lee JH, Jung S, Kim C, Jang MU, Lee J, Lee BC (2016) Aspirin resistance is associated with increased stroke severity and infarct volume. Neurology 86:1808\u20131817. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002657","journal-title":"Neurology"},{"key":"1813_CR6","doi-asserted-by":"publisher","first-page":"e0120743","DOI":"10.1371\/journal.pone.0120743","volume":"10","author":"JT Kim","year":"2015","unstructured":"Kim JT, Heo SH, Lee JS, Choi MJ, Choi KH, Nam TS, Lee SH, Park MS, Kim BC, Kim MK, Cho KH (2015) Aspirin resistance in the acute stages of acute ischemic stroke is associated with the development of new ischemic lesions. PLoS ONE 10:e0120743. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0120743","journal-title":"PLoS ONE"},{"key":"1813_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11239-017-1477-1","volume":"43","author":"KP Bliden","year":"2017","unstructured":"Bliden KP, Chaudhary R, Mohammed N, Muresan AA, Lopez-Espina CG, Cohen E, Raviv G, Doubleday M, Zaman F, Mathew B, Tantry US, Gurbel PA (2017) Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6 s system. J Thromb Thrombolysis 43:437\u2013445. \n                    https:\/\/doi.org\/10.1007\/s11239-017-1477-1","journal-title":"J Thromb Thrombolysis"},{"key":"1813_CR8","doi-asserted-by":"publisher","first-page":"642649","DOI":"10.3109\/09537104.2016.1153617","volume":"27","author":"PA Gurbel","year":"2016","unstructured":"Gurbel PA, Bliden KP, Tantry US, Monroe AL, Muresan AA, Brunner NE, Lopez-Espina CG, Delmenico PR, Cohen E, Raviv G, Haugen DL, Ereth MH (2016) First report of the point-of-care TEG: a technical validation study of the TEG-6S system. Platelets 27:642\u2013649. \n                    https:\/\/doi.org\/10.3109\/09537104.2016.1153617","journal-title":"Platelets"},{"key":"1813_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ahj.2010.05.034","volume":"160","author":"PA Gurbel","year":"2010","unstructured":"Gurbel PA, Bliden KP, Navickas IA, Mahla E, Dichiara J, Suarez TA, Antonino MJ, Tantry US, Cohen E (2010) Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events. Am Heart J 160:346\u2013354. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2010.05.034","journal-title":"Am Heart J"},{"key":"1813_CR10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/01.STR.0000206461.71624.50","volume":"37","author":"D Cocho","year":"2006","unstructured":"Cocho D, Borrell M, Marti-Fabregas J, Montaner J, Castellanos M, Bravo Y, Molina-Porcel L, Belvis R, Diaz-Manera JA, Martinez-Domeno A, Martinez-Lage M, Millan M, Fontcuberta J, Marti-Vilalta JL (2006) Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Stroke 37:996\u2013999. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000206461.71624.50","journal-title":"Stroke"},{"key":"1813_CR11","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1160\/TH17-03-0189","volume":"117","author":"NA Zakai","year":"2017","unstructured":"Zakai NA, Olson NC, Judd SE, Kleindorfer DO, Kissela BM, Howard G, Cushman M (2017) Haemostasis biomarkers and risk of intracerebral haemorrhage in the reasons for geographic and racial differences in stroke study. Thromb Haemost 117:1808\u20131815. \n                    https:\/\/doi.org\/10.1160\/TH17-03-0189","journal-title":"Thromb Haemost"},{"key":"1813_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2217\/bmm.09.30","volume":"3","author":"MB Maas","year":"2009","unstructured":"Maas MB, Furie KL (2009) Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med 3:363\u2013383. \n                    https:\/\/doi.org\/10.2217\/bmm.09.30","journal-title":"Biomark Med"},{"key":"1813_CR13","doi-asserted-by":"publisher","first-page":"e0176622","DOI":"10.1371\/journal.pone.0176622","volume":"12","author":"J Shen","year":"2017","unstructured":"Shen J, Li X, Li Y, Wu B (2017) Comparative accuracy of CT perfusion in diagnosing acute ischemic stroke: a systematic review of 27 trials. PLoS ONE 12:e0176622. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0176622","journal-title":"PLoS ONE"},{"key":"1813_CR14","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1161\/STROKEAHA.117.017076","volume":"48","author":"A Bustamante","year":"2017","unstructured":"Bustamante A, Lopez-Cancio E, Pich S, Penalba A, Giralt D, Garcia-Berrocoso T, Ferrer-Costa C, Gasull T, Hernandez-Perez M, Millan M, Rubiera M, Cardona P, Cano L, Quesada H, Terceno M, Silva Y, Castellanos M, Garces M, Reverte S, Ustrell X, Mares R, Baiges JJ, Serena J, Rubio F, Salas E, Davalos A, Montaner J (2017) Blood biomarkers for the early diagnosis of stroke: the stroke-chip study. Stroke 48:2419\u20132425. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.117.017076","journal-title":"Stroke"},{"key":"1813_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.01.004","volume":"23","author":"DJ Sahlas","year":"2014","unstructured":"Sahlas DJ, Gould L, Swartz RH, Mohammed N, McNicoll-Whiteman R, Naufal F, Oczkowski W (2014) Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes. J Stroke Cerebrovasc Dis 23:155\u2013159. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2013.01.004","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1813_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.09.023","volume":"23","author":"CB Nedelman","year":"2014","unstructured":"Nedelman CB, Glenn LL (2014) Effect of tissue plasminogen activator dose and interval on stroke severity. J Stroke Cerebrovasc Dis 23:197\u2013198. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2013.09.023","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1813_CR17","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/jth.13486","volume":"14","author":"S Testa","year":"2016","unstructured":"Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G (2016) Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter\/multiplatform study. J Thromb Haemost 14:2194\u20132201. \n                    https:\/\/doi.org\/10.1111\/jth.13486","journal-title":"J Thromb Haemost"},{"key":"1813_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2141.2010.08539.x","volume":"152","author":"WO Tobin","year":"2011","unstructured":"Tobin WO, Kinsella JA, Collins DR, Coughlan T, O\u2019Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ (2011) Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study. Br J Haematol 152:640\u2013647. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08539.x","journal-title":"Br J Haematol"},{"key":"1813_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/09537100400020567","volume":"16","author":"DJ McCabe","year":"2005","unstructured":"McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM (2005) Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. Platelets 16:269\u2013280. \n                    https:\/\/doi.org\/10.1080\/09537100400020567","journal-title":"Platelets"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01813-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01813-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01813-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T19:12:38Z","timestamp":1579720358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01813-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1813"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01813-0","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"23 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Gurbel reports serving as a consultant or receiving honoraria for lectures, consultations, including service on speakers\u2019 bureaus from Bayer, Merck, Janssen, Medicure, and World Medical; receiving grants from the National Institutes of Health, Janssen, Bayer, Haemonetics, Instrumentation Labs, Coramed Technologies, LLC and Amgen. Dr. Gurbel is holding stock or stock options in Merck, Medtronic, and Pfizer; and holding patents in the area of personalized antiplatelet therapy and interventional cardiology. Dr. Cochran serves on speakers bureau and does consulting for Merck, Avanir and Amgen. Dr. Raviv reports serving as a consultant for Haemonetics. Other authors report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional ethical committee and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}